MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
OPKO Health P/S Ratio 2011-2026 | OPK
Annual P/S Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.61 | 4.09 | 0.816 | 1.14 | 2.41 | 0.977 | 2.13 | 2.4 | 3.48 | 8.18 | 55.7 | 30 | 40.7 | 52.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 | 0.816 | 15.1 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B |  USA |
 |
Fulgent Genetics
FLGT
|
1.63 | $ 17.27 | 0.94 % | $ 532 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 114.78 | -1.71 % | $ 9.47 B |  Irlanda |
 |
Agilent Technologies
A
|
6.64 | $ 114.47 | -0.43 % | $ 34.8 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Illumina
ILMN
|
3.75 | $ 142.61 | -1.24 % | $ 22.7 B | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 6.97 | 37.42 % | $ 9.27 M | USA |
 |
Castle Biosciences
CSTL
|
1.37 | $ 19.81 | -1.69 % | $ 574 M | USA |
 |
Aspira Women's Health
AWH
|
0.37 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.316 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
13.7 | $ 117.82 | -0.95 % | $ 14.8 B | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 21.77 | 0.65 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.82 | 1.11 % | $ 8.05 M | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 100.16 | -2.76 % | $ 6.76 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.244 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 095.1 | -0.72 % | $ 22.6 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
19.5 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
2.04 | $ 9.07 | -1.68 % | $ 1.16 B | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 18.97 | -0.58 % | $ 425 M | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Natera
NTRA
|
6.47 | $ 201.3 | -0.93 % | $ 19.8 B | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 158.75 | -0.97 % | $ 7.87 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 430.0 | -0.65 % | $ 12.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 3.76 | -1.54 % | $ 348 M | USA |
 |
Personalis
PSNL
|
6.19 | $ 8.71 | 2.72 % | $ 777 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.7 | $ 26.96 | 0.04 % | $ 25.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
9.94 | $ 6.45 | 1.66 % | $ 269 M | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
10.9 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 63.61 | 5.02 % | $ 3.8 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.44 | -1.81 % | $ 5.6 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 259.39 | -0.21 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 444.73 | -0.79 % | $ 168 B | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 339.39 | -0.87 % | $ 20.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
3.15 | $ 0.6 | - | $ 216 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
1.14 | $ 8.98 | 0.9 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 193.84 | -0.7 % | $ 21.5 B | USA |